Status:
WITHDRAWN
Melatonin in Acute Stroke
Lead Sponsor:
University of Florida
Conditions:
Stroke, Acute
Ischemic Stroke
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study will measure Interleukin 6 (IL-6), a well-documented inflammatory biomarker that is increased in the acute phase of stroke, and to compare its levels after the administration of melatonin -...
Detailed Description
Stroke is a major cause of debilitation in the first world, with few therapeutic options when it comes to improvement in quality of life and morbidity, besides physical and occupational therapy. It af...
Eligibility Criteria
Inclusion
- Adult patients admitted to the Neuroscience Critical Care Unit with a confirmed ischemic stroke
- Patients with a clinical history and examination consistent with an ischemic stroke (stroke must be confirmed by a brain CT and/or MRI scan)
- Eligible patients will have been treated with TPA and/or thrombectomy.
Exclusion
- Prisoners
- Patients with severe cognitive impairment and/or aphasia (if no family member is available to sign consent)
- Recent (\<1 month) infection
- Pregnant females
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03843008
Start Date
April 1 2022
End Date
January 1 2023
Last Update
January 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida College of Medicine-Jacksonville
Jacksonville, Florida, United States, 32209